Reduced nontypeable Haemophilus influenzae lower airway infection in children with chronic endobronchial suppuration vaccinated with the 10-valent pneumococcal H. influenzae protein D conjugate vaccine

Vaccine. 2018 Mar 20;36(13):1736-1742. doi: 10.1016/j.vaccine.2018.02.054. Epub 2018 Feb 23.

Abstract

Background: Nontypeable Haemophilus influenzae (NTHi), the most common bacterial lower airway infection in children with protracted bacterial bronchitis, is associated with progression to bronchiectasis. We determined whether vaccination with 10-valent pneumococcal NTHi protein-D conjugate vaccine (PHiD-CV) reduced NTHi lower airway infection compared to children not PHiD-CV-vaccinated. Our unique childhood vaccination schedule and prospective 9-year bronchoalveolar lavage (BAL) collection provided an exclusive opportunity to examine this hypothesis.

Methods: Paired BAL fluids and nasopharyngeal (NP) swabs were collected from 543 children (2007-2016) undergoing bronchoscopy for chronic cough. Children who received a primary course of ≥2 doses of one pneumococcal conjugate vaccine (PCV) and <2 doses of another PCV were included in each vaccine group. Logistic regression determined associations between NTHi lower airway infection (≥104 colony-forming units/mL BAL) and age, sex, Indigenous status, antibiotic exposure, and PHiD-CV vaccination.

Results: Of 262 PCV7-vaccinated, 53 PHiD-CV-vaccinated and 166 PCV13-vaccinated children (62 had mixed schedules, <2 PCV doses or missing vaccination data), NTHi lower airway infection was detected in 89 (34%), 9 (17%) and 47 (28%), respectively. On multivariate regression, significant independent factors associated with reduced NTHi lower airway infection were PHiD-CV vaccination (ORadjusted = 0.42, 95%CI 0.19-0.93), macrolide use (ORadjusted = 0.57, 95%CI 0.35-0.93) and increasing age (ORadjusted = 0.88, 95%CI 0.80-0.96). PHiD-CV vaccination had no impact on NTHi NP carriage.

Conclusions: PHiD-CV-vaccinated children were significantly less likely to have NTHi lower airway infection than children not PHiD-CV-vaccinated. PHiD-CV is likely an effective intervention for reducing NTHi endobronchial infection in children at risk of chronic suppurative lung diseases.

Keywords: Bronchiectasis; Chronic suppurative lung disease; Lower airway infection; Nontypeable Haemophilus influenzae; Pneumococcal conjugate vaccine; Protracted bacterial bronchitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Bacterial Proteins / immunology*
  • Carrier Proteins / immunology*
  • Child
  • Child, Preschool
  • Female
  • Haemophilus Infections / diagnosis
  • Haemophilus Infections / immunology*
  • Haemophilus Infections / microbiology
  • Haemophilus Infections / prevention & control*
  • Haemophilus influenzae / immunology*
  • Humans
  • Immunoglobulin D / immunology*
  • Infant
  • Lipoproteins / immunology*
  • Male
  • Odds Ratio
  • Pneumococcal Vaccines / administration & dosage
  • Pneumococcal Vaccines / immunology*
  • Respiratory Tract Infections / diagnosis
  • Respiratory Tract Infections / immunology*
  • Respiratory Tract Infections / microbiology
  • Respiratory Tract Infections / prevention & control*

Substances

  • 10-valent pneumococcal conjugate vaccine
  • Bacterial Proteins
  • Carrier Proteins
  • Immunoglobulin D
  • Lipoproteins
  • Pneumococcal Vaccines
  • glpQ protein, Haemophilus influenzae